Press release
Lumbosacral Radicular Pain Market is expected to reach $11.7 billion by 2034
Lumbosacral Radicular Pain
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71947
The condition significantly impacts quality of life and productivity. While conservative management (NSAIDs, physical therapy) remains first-line, refractory cases often require epidural steroid injections, radiofrequency ablation, or surgical interventions. With advances in neuromodulation devices, regenerative therapies, and digital health monitoring, the market is set for significant growth.
Market Overview
• Market Size (2024): USD 6.2 billion
• Forecast (2034): USD 11.7 billion
• CAGR (2025-2034): 6.5%
Growth is driven by rising prevalence of lower back disorders, aging populations, and expanding adoption of minimally invasive pain interventions and digital health solutions.
Key Highlights:
• Low back pain is a leading cause of disability worldwide; ~40% of cases involve radicular pain.
• Epidural steroid injections widely used but often temporary.
• Neuromodulation (spinal cord stimulation, dorsal root ganglion stimulation) growing rapidly.
• Regenerative medicine (stem cells, platelet-rich plasma) under clinical research.
Segmentation Analysis
By Product Type:
• Pharmacological Therapies
o NSAIDs & Analgesics
o Muscle Relaxants
o Anticonvulsants (gabapentin, pregabalin)
o Antidepressants (duloxetine, amitriptyline)
o Opioids (limited, refractory cases)
• Interventional Therapies
o Epidural Steroid Injections (ESIs)
o Radiofrequency Ablation (RFA)
o Facet Joint & Nerve Root Blocks
o Surgical Interventions (discectomy, laminectomy)
• Neuromodulation Devices
o Spinal Cord Stimulation (SCS)
o Dorsal Root Ganglion (DRG) Stimulation
• Regenerative Therapies (Pipeline)
o Stem Cell Therapy
o Platelet-Rich Plasma (PRP)
• Digital Pain Management Tools
o AI-Based Pain Tracking Apps
o Remote Monitoring Devices
By Platform:
• Small Molecules (NSAIDs, antidepressants, anticonvulsants)
• Biologics (stem cells, regenerative therapies - research stage)
• Devices (neuromodulation, surgical systems)
• Digital Therapeutics
By Technology:
• Minimally Invasive Pain Procedures (RFA, ESIs)
• Neuromodulation Innovations (closed-loop SCS, DRG stimulation)
• Regenerative Medicine Platforms
• AI-Powered Pain Monitoring
By End Use:
• Hospitals & Orthopedic Centers
• Pain Clinics & Neurology Centers
• Ambulatory Surgical Centers (ASCs)
• Research Institutes
By Application:
• Herniated Disc-Induced Radicular Pain
• Spinal Stenosis-Associated Pain
• Degenerative Disc Disease
• Post-Surgical & Traumatic Radiculopathy
• Clinical Research
Segmentation Summary:
Pharmacological therapies remain first-line, but interventional procedures, neuromodulation, and regenerative therapies represent the fastest-growing categories. Digital pain management platforms are emerging as key adjuncts.
Explore Full Report here: https://exactitudeconsultancy.com/reports/71947/lumbosacral-radicular-pain-market
Regional Analysis
North America
• ~44% share in 2024.
• High prevalence of degenerative disc disease and strong adoption of ESIs and SCS.
• FDA approvals of neuromodulation devices driving growth.
Europe
• ~29% share.
• Germany, UK, and France leading in minimally invasive spine surgery and neuromodulation.
• EMA supporting regenerative medicine clinical research.
Asia-Pacific
• Fastest-growing region with CAGR of ~7.6%.
• High prevalence of lower back pain in aging populations of Japan, China, and India.
• Expanding orthopedic and pain management infrastructure.
Middle East & Africa
• Smaller share but increasing burden of spinal disorders.
• Limited access to advanced pain interventions outside tertiary centers.
Latin America
• Brazil and Mexico driving regional adoption.
• Expanding availability of generics and pain intervention procedures.
Regional Summary:
North America and Europe dominate due to infrastructure and device adoption, while Asia-Pacific grows fastest due to rising prevalence of spinal disorders and healthcare expansion.
Market Dynamics
Key Growth Drivers:
• Rising prevalence of low back pain and radicular neuropathy.
• Growing demand for minimally invasive pain management.
• Increasing adoption of spinal cord and DRG stimulators.
• Emerging regenerative therapies and AI-driven monitoring tools.
Key Challenges:
• High recurrence rates after conservative therapy.
• Limited efficacy and risks of opioids.
• High cost of neuromodulation devices and limited reimbursement.
• Underdiagnosis in low-resource regions.
Latest Trends:
• Closed-loop spinal cord stimulation showing improved outcomes.
• Stem cell and PRP regenerative therapies under investigation.
• AI-powered apps tracking patient-reported outcomes in real time.
• Expansion of outpatient interventional pain management centers.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71947
Competitor Analysis
Major Players in the Market:
• Medtronic plc (Spinal Cord Stimulation Systems)
• Boston Scientific Corporation (neuromodulation portfolio)
• Abbott Laboratories (DRG stimulation, SCS devices)
• Stryker Corporation (surgical and interventional spine portfolio)
• Johnson & Johnson (DePuy Synthes spine solutions)
• Nevro Corp. (HF10 SCS system)
• Pfizer Inc. (NSAIDs, neuropathic pain drugs)
• Eli Lilly and Company (duloxetine)
• Teva Pharmaceutical Industries Ltd. (generics)
• Regenexx & Mesoblast Ltd. (stem cell/regenerative therapy research)
Competitive Summary:
Medtronic, Abbott, Boston Scientific, and Nevro dominate neuromodulation. Stryker and J&J lead spine surgery portfolios. Pfizer and Lilly remain strong in pharmacological therapy, while regenerative medicine firms explore stem cell pipelines. Competition focuses on minimally invasive interventions, neuromodulation innovation, and regenerative pain solutions.
Conclusion
The Lumbosacral Radicular Pain Market, valued at USD 6.2 billion in 2024, is projected to reach USD 11.7 billion by 2034, growing at a CAGR of 6.5%. Expanding adoption of interventional procedures, neuromodulation, and regenerative medicine will continue to drive growth.
Key Takeaways:
• NSAIDs, anticonvulsants, and ESIs dominate current management.
• North America and Europe lead, while Asia-Pacific grows fastest.
• Neuromodulation and regenerative therapies represent high-growth areas.
• AI-driven digital pain management tools enhancing patient monitoring.
The next decade will transform lumbosacral radicular pain care from short-term symptom relief to integrated, technology-driven, and regenerative solutions, creating strong opportunities for pharma, medtech, and digital health innovators.
This report is also available in the following languages : Japanese (腰仙部神経根痛市場), Korean (요추 천골 신경근 통증 시장), Chinese (腰骶根性疼痛市场), French (Marché de la douleur radiculaire lombo-sacrée), German (Markt für lumbosakrale radikuläre Schmerzen), and Italian (Mercato del dolore radicolare lombosacrale), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71947/lumbosacral-radicular-pain-market#request-a-sample
Our More Reports:
Ophthalmic Imaging Equipment Market
https://exactitudeconsultancy.com/reports/72302/ophthalmic-imaging-equipment-market
Myopia Treatment Devices Market
https://exactitudeconsultancy.com/reports/72301/myopia-treatment-devices-market
Corneal Transplant Market
https://exactitudeconsultancy.com/reports/72300/corneal-transplant-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lumbosacral Radicular Pain Market is expected to reach $11.7 billion by 2034 here
News-ID: 4180812 • Views: …
More Releases from Exactitude Consultancy
Infantile Spasm Market is expected to reach USD 590 million by 2034
Infantile spasms (IS), also known as West syndrome, is a rare but severe epileptic encephalopathy that typically presents in infants aged 3-12 months. The condition is characterized by sudden spasms, hypsarrhythmia on EEG, and developmental regression. IS has a profound long-term impact, with many children developing intellectual disability, autism spectrum disorder, or refractory epilepsy.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71941
The global market is expanding due to growing…
Intracerebral Hemorrhage (ICH) Market is expected to reach USD 5.1 billion by 20 …
Intracerebral hemorrhage (ICH) is a severe subtype of stroke characterized by bleeding directly into the brain tissue, often caused by hypertension, cerebral amyloid angiopathy, trauma, or anticoagulant therapy. ICH accounts for 10-15% of all strokes but is associated with disproportionately high rates of mortality and disability.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71943
Currently, management focuses on emergency stabilization, blood pressure control, surgical evacuation in selected cases, and reversal…
Levodopa-Induced Dyskinesia (LID) Market is expected to reach USD 3.0 billion by …
Levodopa remains the gold standard therapy for Parkinson's disease (PD), effectively managing motor symptoms. However, long-term use often leads to levodopa-induced dyskinesia (LID), characterized by involuntary, erratic, and often debilitating movements. LID significantly affects quality of life, complicating treatment strategies for PD patients.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71945
The condition has driven intense clinical research into adjunctive therapies, novel formulations, neuromodulation devices, and digital monitoring tools.…
Multiple Organ Dysfunction Syndrome (MODS) Market to Reach USD 9.7 Billion by 20 …
Multiple Organ Dysfunction Syndrome (MODS) is a life-threatening condition characterized by progressive failure of two or more organ systems, often resulting from sepsis, severe trauma, burns, or systemic inflammatory response syndrome (SIRS). It is the leading cause of death in intensive care units (ICUs) worldwide, with mortality rates ranging between 30-80% depending on severity.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71949
As global populations age and chronic conditions increase,…
More Releases for Pain
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical…
